MKI67 and lung carcinoma: However, use of ADCmin may provide new insight to the evaluation of lung cancer including benign-malignant discrimination, the possibility of evaluation all lesions and lymph nodes noninvasively, even in the cases that tissue sampling is difficult, as well as predicting the prognosis of tumour by using it as a surrogate marker of Ki-67 index.